Gryphon Sciences
South San Francisco, CA, US· latest recorded location
Gryphon Sciences is named on 6 US grants and 0 published applications in this corpus. Its most frequent classification is C07K (Peptides).
- Granted patents
- 6
- Published applications
- 0
- Inventors
- 10
- Granted in 2026 so far
- 0
- Most recent grant
- 17 Sep 2002
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1999 | 1 | 0 |
| 2000 | 0 | 0 |
| 2001 | 4 | 0 |
| 2002 | 1 | 0 |
By publication year.
Technology areas
Share of 6 documents
Recent patents
- Lipid matrix-assisted chemical ligation and synthesis of membrane polypeptides17 Sep 2002US 6,451,543 B1
- Solid phase native chemical ligation of unprotected or n-terminal cysteine protected peptides in aqueous solution4 Dec 2001US 6,326,468 B1
- Polyoxime compounds and their preparation17 Apr 2001US 6,217,873 B1
- Homogeneous polyoxime compositions and their preparation by parallel assembly16 Jan 2001US 6,174,530 B1
- N-terminal modifications of RANTES and methods of use2 Jan 2001US 6,168,784 A
No published applications.
Most cited
By later US patents
- Solid phase native chemical ligation of unprotected or n-terminal cysteine protected peptides in aqueous solution70US 6,326,468 B12001
- Lipid matrix-assisted chemical ligation and synthesis of membrane polypeptides41US 6,451,543 B12002
- Homogeneous polyoxime compositions and their preparation by parallel assembly30US 6,174,530 B12001
- Hetero-polyoxime compounds and their preparation by parallel assembly27US 6,001,364 A1999
- N-terminal modifications of RANTES and methods of use26US 6,168,784 A2001